{ "cik": 1157601, "cik_padded": "0001157601", "entityName": "MADRIGAL PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0001628280-26-009514", "filed": "2026-02-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 467000.0, "cash": 198693000.0, "eps_diluted": -12.85, "free_cash_flow": -190020000.0, "net_income": -288284000.0, "operating_cash_flow": -189553000.0, "operating_income": -300097000.0, "revenue": 958403000.0, "stockholders_equity": 602689000.0, "total_assets": 1259589000.0, "total_liabilities": 656900000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0899485472606933, "net_margin": -0.30079622037910986, "operating_margin": -0.31312193304904096, "revenue_growth_yoy": 4.320529830736178, "roa_avg2y": -0.25048178931948234, "roa_period_end": -0.22887148109422994, "roe_avg2y": -0.4248617612035323, "roe_period_end": -0.47832961942228913 } }, { "accn": "0001628280-26-009514", "filed": "2026-02-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1462000.0, "cash": 100019000.0, "eps_diluted": -21.9, "free_cash_flow": -457034000.0, "net_income": -465892000.0, "operating_cash_flow": -455572000.0, "operating_income": -497875000.0, "revenue": 180133000.0, "stockholders_equity": 754383000.0, "total_assets": 1042247000.0, "total_liabilities": 287864000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3815886625228829, "roa_avg2y": -0.5537124567831833, "roa_period_end": -0.4470072833023266, "roe_avg2y": -0.8034587778387122, "roe_period_end": -0.6175801946756488 } }, { "accn": "0001628280-26-009514", "filed": "2026-02-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1479000.0, "cash": 99915000.0, "eps_diluted": -19.99, "free_cash_flow": -325709000.0, "net_income": -373630000.0, "operating_cash_flow": -324230000.0, "operating_income": -380496000.0, "stockholders_equity": 405333000.0, "total_assets": 640547000.0, "total_liabilities": 235214000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5802981745873146, "roa_avg2y": -0.7449365429226243, "roa_period_end": -0.5832983372024223, "roe_avg2y": -1.239808734375052, "roe_period_end": -0.9217852975208038 } }, { "accn": "0001628280-26-009514", "filed": "2026-02-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 217000.0, "cash": 331549000.0, "eps_diluted": -17.23, "free_cash_flow": -225074000.0, "net_income": -295350000.0, "operating_cash_flow": -224857000.0, "operating_income": -293571000.0, "stockholders_equity": 197389000.0, "total_assets": 362572000.0, "total_liabilities": 165183000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8368399454883504, "roa_avg2y": -0.9289137983091788, "roa_period_end": -0.8145968249065014, "roe_avg2y": -1.5011588427836624, "roe_period_end": -1.496283987456241 } }, { "accn": "0001628280-25-007980", "filed": "2025-02-26", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 209000.0, "cash": 36269000.0, "eps_diluted": -14.63, "free_cash_flow": -184126000.0, "net_income": -241846000.0, "operating_cash_flow": -183917000.0, "operating_income": -242482000.0, "stockholders_equity": 196107000.0, "total_assets": 273332000.0, "total_liabilities": 77225000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.39379012477881975, "roa_avg2y": -0.863231648662299, "roa_period_end": -0.8848067551549031, "roe_avg2y": -1.1091894321415714, "roe_period_end": -1.233234917672495 } }, { "accn": "0001628280-24-007376", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 334000.0, "cash": 54004000.0, "eps_diluted": -13.09, "free_cash_flow": -157895000.0, "net_income": -202244000.0, "operating_cash_flow": -157561000.0, "operating_income": -206673000.0, "stockholders_equity": 239970000.0, "total_assets": 286995000.0, "total_liabilities": 47025000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.19596199524940616, "roa_avg2y": -0.5548144094171739, "roa_period_end": -0.7046952037491943, "roe_avg2y": -0.6160951053637659, "roe_period_end": -0.8427886819185731 } }, { "accn": "0001193125-23-060052", "filed": "2023-03-03", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 172000.0, "cash": 46697000.0, "free_cash_flow": -41796000.0, "net_income": -83948000.0, "operating_cash_flow": -41624000.0, "operating_income": -94972000.0, "stockholders_equity": 416565000.0, "total_assets": 442056000.0, "total_liabilities": 25491000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06119333117280616, "roa_avg2y": -0.18102306886156527, "roa_period_end": -0.1899035416327343, "roe_avg2y": -0.18789792165846528, "roe_period_end": -0.20152437194675504 } }, { "accn": "0001193125-22-051569", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 22000.0, "cash": 57379000.0, "free_cash_flow": -25529000.0, "net_income": -32811000.0, "operating_cash_flow": -25507000.0, "operating_income": -40682000.0, "stockholders_equity": 476984000.0, "total_assets": 485428000.0, "total_liabilities": 8444000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.017702899887627258, "roa_avg2y": -0.0968245981872131, "roa_period_end": -0.06759189828357655, "roe_avg2y": -0.09954144374684297, "roe_period_end": -0.0687884708921054 } }, { "accn": "0001193125-21-056164", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 125000.0, "cash": 148627000.0, "free_cash_flow": -22442000.0, "net_income": -31154000.0, "operating_cash_flow": -22317000.0, "operating_income": -32062000.0, "stockholders_equity": 182259000.0, "total_assets": 192313000.0, "total_liabilities": 10054000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05516325668416923, "roa_avg2y": -0.2668174012838136, "roa_period_end": -0.16199632890132232, "roe_avg2y": -0.28494208141071664, "roe_period_end": -0.17093257397439907 } }, { "accn": "0001193125-20-049021", "filed": "2020-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3000.0, "cash": 19145000.0, "free_cash_flow": -17611000.0, "net_income": -26388000.0, "operating_cash_flow": -17608000.0, "operating_income": -25223000.0, "stockholders_equity": 36410000.0, "total_assets": 41210000.0, "total_liabilities": 4800000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1318319143092557, "roa_period_end": -0.6403300169861684, "roe_period_end": -0.7247459489151332 } }, { "accn": "0001047469-12-001243", "filed": "2012-02-22", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -1.0 }, "period_end": "2011-12-31", "ratios": {} }, { "accn": "0001047469-12-001243", "filed": "2012-02-22", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.93 }, "period_end": "2010-12-31", "ratios": {} }, { "accn": "0001047469-12-001243", "filed": "2012-02-22", "fiscal_year": 2009, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": 2.32 }, "period_end": "2009-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-009514", "filed": "2026-02-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001157601.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001157601.json" }, "ticker": "MDGL" }